Senate Bill
S. 2157
Gun Violence Prevention Through Financial Intelligence Act
Primary Sponsor

Edward J. Markey
Senator
Cosponsors
1
Quick Stats
Policy Area
Summary
This bill aims to repeal several programs and requirements that were put in place by the Inflation Reduction Act of 2022 to help lower the prices of prescription drugs for people on Medicare. If it becomes law, this bill would remove the ability for the government to negotiate drug prices, get rid of penalties for drug companies that raise prices faster than inflation, and remove the cap on how much Medicare patients have to pay out-of-pocket for their medications.
Latest Action
Read twice and referred to the Committee on Finance.
See this page through your district lens
Enter ZIP to personalize representatives and vote context.
Stay on top of this issue
Subscribe for weekly bill and representative updates.
Vote Prediction
Gun Violence Prevention Through Financial Intelligence Act
This bill aims to repeal several programs and requirements that were put in place by the Inflation Reduction Act of 2022 to help lower the prices of prescription drugs for people on Medicare. If it becomes law, this bill would remove the ability for the govern
Community Breakdown
Pass
0%
Fail
0%
0 predictions
This bill aims to repeal several programs and requirements that were put in place by the Inflation Reduction Act of 2022 to help lower the prices of prescription drugs for people on Medicare. If it becomes law, this bill would remove the ability for the government to negotiate drug prices, get rid of penalties for drug companies that raise prices faster than inflation, and remove the cap on how much Medicare patients have to pay out-of-pocket for their medications.
- Bill Number
- 2157
- Sponsor
- Edward J. Markey (D-MA)
- Introduced
- 6/24/2025
- Status
- Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
- Policy Area
- Health
Data from Congress.gov
Fact Sheet
- Title
- Gun Violence Prevention Through Financial Intelligence Act
- Bill Number
- 2157
- Sponsor
- Edward J. Markey (D-MA)
- Status
- Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
- Introduced
- 6/24/2025
- Summary
- This bill aims to repeal several programs and requirements that were put in place by the Inflation Reduction Act of 2022 to help lower the prices of prescription drugs for people on Medicare. If it becomes law, this bill would remove the ability for the government to negotiate drug prices, get rid o
Data from Congress.gov
Public Opinions
Community submissions related to this bill.
No public opinions yet. Be the first to submit one for this bill.
Related Bills in Health
Empowering Patient Choice of Medical Care Act
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means
To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.
Referred to the House Committee on Energy and Commerce.
Anti-Racism in Public Health Act of 2025
Referred to the House Committee on Energy and Commerce.
SOAR Act of 2025
Read twice and referred to the Committee on Finance.